Clinical features and outcome of SIL/TAL1-positive T-cell acute lymphoblastic leukemia in children and adolescents: a 10-year experience of the AIEOP group
Author(s) -
Magali D'Angio,
Maria Grazia Valsecchi,
A. M. Testi,
Valentino Conter,
Vinícius Santaunes,
Rosanna Parasole,
Antonella Colombini,
Nicola Santoro,
Stefania Varotto,
Michael Caniglia,
D. Silvestri,
Caterina Consarino,
Lauretta Levati,
Elisa Magrin,
Franco Locatelli,
Giuseppe Basso,
Robin Foà,
Andrea Biondi,
Giovanni Cazzaniga
Publication year - 2014
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2014.112151
Subject(s) - lymphoblastic leukemia , medicine , pediatrics , leukemia , gerontology
T-cell acute lymphoblastic leukemia (T-ALL) accounts for approximately 15% and 25% of childhood and adult cases of ALL, respectively,1,2 and is associated with a less favorable outcome.1 In recent years, however, more intensive and risk-adapted treatment has significantly improved the outcome of patients with T-ALL, leading to cure rates approaching 70% in children and adolescents, and 30%-40% in adults.2–4
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom